Langdon, S. P., Kay, C., Um, I. H., Dodds, M., Muir, M., Sellar, G., . . . Harrison, D. J. (2019). Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models. Sci Rep.

Langdon, Simon P., Charlene Kay, In Hwa Um, Michael Dodds, Morwenna Muir, Grant Sellar, Julie Kan, Charlie Gourley, and David J. Harrison. "Evaluation of the Dual MTOR/PI3K Inhibitors Gedatolisib (PF-05212384) and PF-04691502 against Ovarian Cancer Xenograft Models." Sci Rep 2019.

Langdon, Simon P., et al. "Evaluation of the Dual MTOR/PI3K Inhibitors Gedatolisib (PF-05212384) and PF-04691502 against Ovarian Cancer Xenograft Models." Sci Rep 2019.